Article info

Download PDFPDF

Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD
Free

Authors

  1. Correspondence to Dr Maurizio Benucci, Rheumatology Unit, Ospedale San Giovanni di Dio, Firenze 50143, Toscana, Italy; maubenucci{at}tiscali.it
View Full Text

Citation

Benucci M, Damiani A, Giannasi G, et al
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD

Publication history

  • Received June 5, 2020
  • Revised June 9, 2020
  • Accepted June 27, 2020
  • First published July 6, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.